Abstract

Background Estrogen receptor (ER) status has been used as a biomarker in breast carcinomas (BC), allowing the identification of tumors that may respond to ER antagonists or aromatase inhibitors. Two previous studies by our group evaluating gene and miRNA expression profiles in BC samples from Brazilian patients revealed 15 genes and 3 microRNAs as significantly associated with BC, according to ER status. The aim of this study was to evaluate the correlation between these 3 microRNAs and ER-related genes in BC.

Highlights

  • Estrogen receptor (ER) status has been used as a biomarker in breast carcinomas (BC), allowing the identification of tumors that may respond to ER antagonists or aromatase inhibitors

  • Two previous studies by our group evaluating gene and miRNA expression profiles in BC samples from Brazilian patients revealed 15 genes and 3 microRNAs as significantly associated with BC, according to ER status

  • C. Camargo Cancer Treatment and Research Center, São Paulo, SP, Brazil

Read more

Summary

Objectives

The aim of this study was to evaluate the correlation between these 3 microRNAs and ER-related genes in BC

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.